202 related articles for article (PubMed ID: 15465193)
1. Prostate volume measurement by transrectal ultrasound and computed tomography before and after permanent prostate brachytherapy.
Solhjem MC; Davis BJ; Pisansky TM; Wilson TM; Mynderse LA; Herman MG; King BF; Geyer SM
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):767-76. PubMed ID: 15465193
[TBL] [Abstract][Full Text] [Related]
2. Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy.
Igidbashian L; Donath D; Carrier JF; Lassalle S; Hervieux Y; David S; Bahary JP; Taussky D
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):605-9. PubMed ID: 18793964
[TBL] [Abstract][Full Text] [Related]
3. CT-based postimplant dosimetry of prostate brachytherapy: comparison of 1-mm and 5-mm section CT.
Tanaka O; Hayashi S; Kanematsu M; Matsuo M; Nakano M; Maeda S; Deguchi T; Hoshi H
Radiat Med; 2007 Jan; 25(1):22-6. PubMed ID: 17225049
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
Bowes D; Crook JM; Araujo C; Batchelar D
Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
[TBL] [Abstract][Full Text] [Related]
5. MRI-CT fusion to assess postbrachytherapy prostate volume and the effects of prolonged edema on dosimetry following transperineal interstitial permanent prostate brachytherapy.
Crook J; McLean M; Yeung I; Williams T; Lockwood G
Brachytherapy; 2004; 3(2):55-60. PubMed ID: 15374536
[TBL] [Abstract][Full Text] [Related]
6. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
[TBL] [Abstract][Full Text] [Related]
7. Brachytherapy in patients with small prostate glands.
Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
[TBL] [Abstract][Full Text] [Related]
8. Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds.
Sugawara A; Nakashima J; Kunieda E; Nagata H; Asakura H; Oya M; Shigematsu N
Radiat Oncol; 2010 Sep; 5():86. PubMed ID: 20875137
[TBL] [Abstract][Full Text] [Related]
9. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
[TBL] [Abstract][Full Text] [Related]
10. MRI-based preplanning in low-dose-rate prostate brachytherapy.
Tanaka O; Hayashi S; Matsuo M; Nakano M; Kubota Y; Maeda S; Ohtakara K; Deguchi T; Hoshi H
Radiother Oncol; 2008 Jul; 88(1):115-20. PubMed ID: 17933407
[TBL] [Abstract][Full Text] [Related]
11. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
Xue J; Waterman F; Handler J; Gressen E
Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
[TBL] [Abstract][Full Text] [Related]
12. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the feasibility of using transrectal ultrasound for postimplant dosimetry in low-dose-rate prostate brachytherapy.
Davies RS; Perrett T; Powell J; Barber J; Tanguay J; Button M; Cochlin D; Smith C; Lester JF
Med Dosim; 2016 Winter; 41(4):290-295. PubMed ID: 27623391
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
16. Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.
Chung E; Stenmark MH; Evans C; Narayana V; McLaughlin PW
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1944-8. PubMed ID: 21640498
[TBL] [Abstract][Full Text] [Related]
17. A comparison of preplan transrectal ultrasound with preplan-CT in assessing volume and number of seeds needed for real-time ultrasound-based intra-operative planning in prostate (125)I seed implantation.
Fogh S; Doyle L; Yu A; Li J; Weiner P; Suh D; Comber E; Dicker AP; Yu Y; Xiao Y; Harrison A
Brachytherapy; 2010; 9(4):335-40. PubMed ID: 20226742
[TBL] [Abstract][Full Text] [Related]
18. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
[TBL] [Abstract][Full Text] [Related]
19. Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implication.
Chira C; Delouya G; Larrivée S; Carrier JF; Taussky D
Radiat Oncol; 2013 Jul; 8():177. PubMed ID: 23837971
[TBL] [Abstract][Full Text] [Related]
20. Comparison between postoperative TRUS-CT fusion with MRI-CT fusion for postimplant quality assurance in prostate LDR permanent seed brachytherapy.
Tisseverasinghe S; Marbán M; Crook J; Petrik D; Araujo C
Brachytherapy; 2021; 20(4):849-856. PubMed ID: 33867295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
